Abecma, Breyanzi, CARVYKTI, Kymiah, Tecartus, Yeskarta
Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha
Horudhac Qaybta Oncology, immunotherapy waxay u soo baxday hab horudhac ah, oo ka faa'iidaysanaysa habka difaaca jidhka si loola dagaallamo burooyinka halista ah. Waxaa jira habab badan oo difaaca jirka ah, laakiin Chimeric Antigen Rece.
Breyanzi, Juno Therapeutics, Lymphoma-ka weyn ee B-cell, LBCL, beddesho
Lisocabtagene maraleucel waxa u ansixisay FDA daawaynta safka labaad ee lymfoma B-cell weyn
Luulyo 2022: Lisocabtagene maraleucel (Breyanzi, Juno Therapeutics, Inc.) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee bukaanada qaangaarka ah ee qaba lymphoma weyn ee B-cell (LBCL) kuwaas oo qaba cudurka refractory ee chemoi-ka koowaad.
BMS, Breyanzi, CAR - T Daaweynta unugyada, GARGAARKA GARGAARKA, Daaweynta CART, USFDA
Breyanzi - Daaweynta cusub ee CAR T-Cell ee laga helo BMS
Julaay 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), novel CD19-directed chimeric antigen receptor (CAR) T unug ay samaysay Bristol Myers Squibb (BMS), waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka ee Maraykanka (US.